2021 Q1 Form 10-Q Financial Statement

#000162747521000022 Filed on May 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $113.6M $83.20M
YoY Change 36.57% 21.5%
Cost Of Revenue $30.44M $23.49M
YoY Change 29.62% 11.17%
Gross Profit $83.18M $59.71M
YoY Change 39.3% 26.1%
Gross Profit Margin 73.21% 71.77%
Selling, General & Admin $63.14M $48.50M
YoY Change 30.17% 34.06%
% of Gross Profit 75.9% 81.23%
Research & Development $26.61M $19.35M
YoY Change 37.55% 22.46%
% of Gross Profit 32.0% 32.4%
Depreciation & Amortization $1.000M $700.0K
YoY Change 42.86% -12.5%
% of Gross Profit 1.2% 1.17%
Operating Expenses $90.88M $68.76M
YoY Change 32.16% 30.69%
Operating Profit -$7.697M -$9.051M
YoY Change -14.96% 71.91%
Interest Expense $199.0K $230.0K
YoY Change -13.48% -38.34%
% of Operating Profit
Other Income/Expense, Net $78.00K -$731.0K
YoY Change -110.67% -252.61%
Pretax Income -$7.818M -$10.01M
YoY Change -21.91% 94.07%
Income Tax $17.00K $9.000K
% Of Pretax Income
Net Earnings -$7.835M -$10.02M
YoY Change -21.81% 94.21%
Net Earnings / Revenue -6.9% -12.05%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.06 -$87.64K
COMMON SHARES
Basic Shares Outstanding 125.3M shares 113.9M shares
Diluted Shares Outstanding 125.3M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $169.8M $145.3M
YoY Change 16.86% 19.88%
Cash & Equivalents $104.3M $65.64M
Short-Term Investments $65.50M $79.70M
Other Short-Term Assets $172.1M $132.0M
YoY Change 30.38% 4.1%
Inventory
Prepaid Expenses
Receivables $51.89M $35.26M
Other Receivables $0.00 $0.00
Total Short-Term Assets $393.9M $312.5M
YoY Change 26.03% 5.5%
LONG-TERM ASSETS
Property, Plant & Equipment $27.87M $24.99M
YoY Change 11.52% 98.26%
Goodwill $118.2M $118.2M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.560M $1.040M
YoY Change 50.0% -25.13%
Total Long-Term Assets $166.5M $169.5M
YoY Change -1.81% 23.25%
TOTAL ASSETS
Total Short-Term Assets $393.9M $312.5M
Total Long-Term Assets $166.5M $169.5M
Total Assets $560.3M $482.1M
YoY Change 16.24% 11.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.08M $1.719M
YoY Change 602.73% 11.48%
Accrued Expenses $26.80M $23.40M
YoY Change 14.53% 50.0%
Deferred Revenue $18.16M $14.39M
YoY Change 26.21% 32.79%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.586M $22.59M
YoY Change -66.42% -30.64%
Total Short-Term Liabilities $226.0M $185.6M
YoY Change 21.73% 8.76%
LONG-TERM LIABILITIES
Long-Term Debt $1.263M $8.814M
YoY Change -85.67% -46.1%
Other Long-Term Liabilities $7.867M $6.384M
YoY Change 23.23% 129.64%
Total Long-Term Liabilities $9.130M $15.20M
YoY Change -39.93% -20.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $226.0M $185.6M
Total Long-Term Liabilities $9.130M $15.20M
Total Liabilities $254.8M $223.3M
YoY Change 14.11% 17.65%
SHAREHOLDERS EQUITY
Retained Earnings -$202.7M -$182.0M
YoY Change 11.36% 22.77%
Common Stock $508.2M $440.7M
YoY Change 15.3% 12.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $305.5M $258.7M
YoY Change
Total Liabilities & Shareholders Equity $560.3M $482.1M
YoY Change 16.24% 11.13%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$7.835M -$10.02M
YoY Change -21.81% 94.21%
Depreciation, Depletion And Amortization $1.000M $700.0K
YoY Change 42.86% -12.5%
Cash From Operating Activities $1.876M -$1.702M
YoY Change -210.22% -94.21%
INVESTING ACTIVITIES
Capital Expenditures $70.00K $1.288M
YoY Change -94.57% -64.26%
Acquisitions
YoY Change
Other Investing Activities $10.02M $6.210M
YoY Change 61.35% -108.66%
Cash From Investing Activities $7.656M $2.924M
YoY Change 161.83% -103.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $27.06M $31.11M
YoY Change -12.99% -34.74%
NET CHANGE
Cash From Operating Activities $1.876M -$1.702M
Cash From Investing Activities $7.656M $2.924M
Cash From Financing Activities $27.06M $31.11M
Net Change In Cash $36.60M $32.33M
YoY Change 13.2% -155.49%
FREE CASH FLOW
Cash From Operating Activities $1.876M -$1.702M
Capital Expenditures $70.00K $1.288M
Free Cash Flow $1.806M -$2.990M
YoY Change -160.4% -90.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19714000 USD
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
UPWORK INC.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001627475
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-38678
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4337682
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
475 Brannan Street, Suite 430
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco,
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94107
CY2021Q1 dei City Area Code
CityAreaCode
650
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
316-7500
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2021Q1 dei Trading Symbol
TradingSymbol
UPWK
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126144849 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104316000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94081000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
65513000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
75570000 USD
CY2021Q1 us-gaap Escrow Deposit
EscrowDeposit
161403000 USD
CY2020Q4 us-gaap Escrow Deposit
EscrowDeposit
135042000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1792000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1661000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51894000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47018000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10742000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9090000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
393868000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
360801000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27868000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28139000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
118219000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
118219000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
667000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18818000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19729000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1560000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1672000 USD
CY2021Q1 us-gaap Assets
Assets
560333000 USD
CY2020Q4 us-gaap Assets
Assets
529227000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12080000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6455000 USD
CY2021Q1 upwk Escrow Funds Payable
EscrowFundsPayable
161403000 USD
CY2020Q4 upwk Escrow Funds Payable
EscrowFundsPayable
135042000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7586000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7581000 USD
CY2021Q1 upwk Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
26762000 USD
CY2020Q4 upwk Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
32868000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18157000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16801000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
225988000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
198747000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1263000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3142000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20506000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7867000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7522000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
254832000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
229917000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
125962107 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125962107 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124795222 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124795222 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
508147000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
494122000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202659000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-194824000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
305501000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
299310000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
560333000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529227000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113619000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83196000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30441000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23485000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
83178000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
59711000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26613000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19348000 USD
CY2020Q1 upwk Provision For Transaction Losses
ProvisionForTransactionLosses
912000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
39604000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30678000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23531000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17824000 USD
CY2021Q1 upwk Provision For Transaction Losses
ProvisionForTransactionLosses
1127000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
90875000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
68762000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7697000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9051000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
199000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
230000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-731000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7818000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10012000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7835000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-10021000 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
125279000 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
114119000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
299310000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2597000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11264000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
165000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7835000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
305501000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
259424000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3165000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5327000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
841000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-10021000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
258736000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-7835000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-10021000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
901000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
767000 USD
CY2021Q1 upwk Depreciation And Amortization Excluding Amortization Of Financing Costs
DepreciationAndAmortizationExcludingAmortizationOfFinancingCosts
3194000 USD
CY2020Q1 upwk Depreciation And Amortization Excluding Amortization Of Financing Costs
DepreciationAndAmortizationExcludingAmortizationOfFinancingCosts
2308000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
19000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13000 USD
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-10000 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
174000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1540000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
650000 USD
CY2021Q1 upwk Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
911000 USD
CY2020Q1 upwk Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
969000 USD
CY2021Q1 upwk Increase Decrease In Common Stock Warrant
IncreaseDecreaseInCommonStockWarrant
188000 USD
CY2020Q1 upwk Increase Decrease In Common Stock Warrant
IncreaseDecreaseInCommonStockWarrant
188000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11226000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5537000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5584000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5891000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1542000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
464000 USD
CY2021Q1 upwk Increase Decrease Operating Lease Liability
IncreaseDecreaseOperatingLeaseLiability
-401000 USD
CY2020Q1 upwk Increase Decrease Operating Lease Liability
IncreaseDecreaseOperatingLeaseLiability
-459000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5540000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
994000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6291000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3881000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1876000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1702000 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
20976000 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
26789000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
31000000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
33000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1288000 USD
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2298000 USD
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1999000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7656000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2924000 USD
CY2021Q1 upwk Changes In Escrow Funds Payable
ChangesInEscrowFundsPayable
26360000 USD
CY2020Q1 upwk Changes In Escrow Funds Payable
ChangesInEscrowFundsPayable
14834000 USD
CY2021Q1 upwk Proceeds From Exercises Of Stock Options And Common Stock Warrant
ProceedsFromExercisesOfStockOptionsAndCommonStockWarrant
2597000 USD
CY2020Q1 upwk Proceeds From Exercises Of Stock Options And Common Stock Warrant
ProceedsFromExercisesOfStockOptionsAndCommonStockWarrant
3165000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1893000 USD
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1893000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27064000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31106000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36596000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32328000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232463000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159603000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269059000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191931000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
105000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
239000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
173000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2435000 USD
CY2021Q1 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
0 USD
CY2020Q1 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
40000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the periods presented. Such estimates include, but are not limited to: the useful lives of assets; assessment of the recoverability of long-lived assets; goodwill impairment; standalone selling price of material rights and the period of time over which to defer and recognize the consideration allocated to the material rights; allowance for doubtful accounts; liabilities relating to transaction losses; stock-based compensation; and accounting for income taxes. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances. The Company evaluates its estimates, assumptions, and judgments on an ongoing basis using historical experience and other factors and revises them when facts and circumstances dictate.</span></div>
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22500000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
18200000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51894000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47018000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18157000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16801000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4361000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4177000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6200000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5100000 USD
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
155549000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
147292000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8900000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10800000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104316000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94081000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
3340000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
3340000 USD
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1500000 USD
CY2020Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
900000 USD
CY2021Q1 upwk Funds Held In Escrow Including Funds In Transit
FundsHeldInEscrowIncludingFundsInTransit
161403000 USD
CY2020Q4 upwk Funds Held In Escrow Including Funds In Transit
FundsHeldInEscrowIncludingFundsInTransit
135042000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269059000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232463000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45770000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43513000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17902000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15374000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27868000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28139000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
1000000.0 USD
CY2020Q1 us-gaap Depreciation
Depreciation
700000 USD
CY2021Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
2100000 USD
CY2020Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1600000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 USD
CY2021Q1 upwk Accrued Compensation And Related Benefits Current
AccruedCompensationAndRelatedBenefitsCurrent
9203000 USD
CY2020Q4 upwk Accrued Compensation And Related Benefits Current
AccruedCompensationAndRelatedBenefitsCurrent
14007000 USD
CY2021Q1 upwk Accrued Freelancer Costs Current
AccruedFreelancerCostsCurrent
963000 USD
CY2020Q4 upwk Accrued Freelancer Costs Current
AccruedFreelancerCostsCurrent
1235000 USD
CY2021Q1 upwk Accrued Indirect Taxes Current
AccruedIndirectTaxesCurrent
2522000 USD
CY2020Q4 upwk Accrued Indirect Taxes Current
AccruedIndirectTaxesCurrent
3818000 USD
CY2021Q1 upwk Accrued Vendor Expenses Current
AccruedVendorExpensesCurrent
8036000 USD
CY2020Q4 upwk Accrued Vendor Expenses Current
AccruedVendorExpensesCurrent
8662000 USD
CY2021Q1 upwk Accrued Payment Processing Fees Current
AccruedPaymentProcessingFeesCurrent
1618000 USD
CY2020Q4 upwk Accrued Payment Processing Fees Current
AccruedPaymentProcessingFeesCurrent
1219000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4116000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3725000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
304000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
202000 USD
CY2021Q1 upwk Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
26762000 USD
CY2020Q4 upwk Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
32868000 USD
CY2021Q1 upwk Letters Of Credit Held
LettersOfCreditHeld
3 letter
CY2020Q4 upwk Letters Of Credit Held
LettersOfCreditHeld
3 letter
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000.0 USD
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000.0 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8857000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10750000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
27000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
8849000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
10723000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7586000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7581000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1263000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3142000 USD
CY2021Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0439
CY2020Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0564
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
49000000.0 USD
CY2021Q1 upwk Adjusted Liquidity Ratio
AdjustedLiquidityRatio
1.75
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7835000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-10021000 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
125279109 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
114118958 shares
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12325794 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21218487 shares
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113619000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83196000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113619000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83196000 USD

Files In Submission

Name View Source Status
0001627475-21-000022-index-headers.html Edgar Link pending
0001627475-21-000022-index.html Edgar Link pending
0001627475-21-000022.txt Edgar Link pending
0001627475-21-000022-xbrl.zip Edgar Link pending
exhibit101stockoptionagree.htm Edgar Link pending
exhibit102svbfifthamendment.htm Edgar Link pending
exhibit3111q21.htm Edgar Link pending
exhibit3121q21.htm Edgar Link pending
exhibit3211q21.htm Edgar Link pending
exhibit3221q21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
upwk-20210331.htm Edgar Link pending
upwk-20210331.xsd Edgar Link pending
upwk-20210331_cal.xml Edgar Link unprocessable
upwk-20210331_def.xml Edgar Link unprocessable
upwk-20210331_htm.xml Edgar Link completed
upwk-20210331_lab.xml Edgar Link unprocessable
upwk-20210331_pre.xml Edgar Link unprocessable